Blog

International researchers are using molecular profiling to identify different types of pleural mesothelioma tumors, according to an October 2019 study. These profiles allow doctors to distinguish tumors that otherwise look very similar under a microscope, which is essential to making a correct diagnosis and administering the most effective treatments. New Findings May Help Malignant Pleural

Photo Credit: 2019 Novocure. All rights reserved. The U.S. Food & Drug Administration (FDA) recently approved a breakthrough treatment option for malignant pleural mesothelioma patients. Novocure’s NovoTTF-100L offers new hope, with clinical trials improving the prognosis of patients who used it with chemotherapy. It is the first new treatment option for the deadly disease to

At a recent International Symposium on Malignant Mesothelioma, three doctors representing some of the biggest organizations behind mesothelioma treatment discussed what patients should look for to determine a truly outstanding mesothelioma treatment center. The quality of the center you choose for your care may determine your treatment options, your prognosis, and overall, your quality of